- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05848180
Ankle Proprioceptive Training In Patients With Diabetic Peripheral Neuropathy
October 11, 2023 updated by: Riphah International University
Effect Of Ankle Proprioceptive Training On Balance And Risk Of Fall In Patients With Diabetic Peripheral Neuropathy
Diabetes being a very prevalent condition results in various complications including neuropathy, which can impair various functional outcomes in patients including balance.
Ankle proprioceptive training (APT) is an intervention that is used to tackle this problem.
The study will compare APT with standard balance training in subjects with diabetic neuropathy.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The study will include the diagnosed diabetic subjects with score of 4 or more on Douleur neuropathique 4 questionnaire (DN4Q).
The subjects will be randomly divided into 2 groups; interventional group and control group.
Interventional group will receive APT 3 days a week for 8 weeks.
Balance training exercises will be given to both groups 3 days a week for 8 weeks.
The assessments will be done at baseline, after 4 weeks and after 8 weeks of interventions.
Study Type
Interventional
Enrollment (Actual)
62
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Islamabad Capital Territory
-
Islamabad, Islamabad Capital Territory, Pakistan, 44000
- Capital developmental authority hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Known case of diabetic peripheral neuropathy (DPN),
- Patients who met the criteria of DN4 scored equal or greater than 4.
- Patients who have positive SHARPEND ROMBERG TEST
Exclusion Criteria:
- Patients with DVT
- orthostatic hypotension
- Any recent surgery of lower limb
- Amputies
- Patients with crutches or walking aids
- Patients with gangrene
- Lower BMI
- Acute systemic illness
- Vestibular impairment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Iinterventional group
Ankle proprioceptive and balance training 3 days a week for 8 weeks.
|
APT comprise of exercises including towel curls, uni-leg stance on foam with activity, writing alphabets on gym ball with toes, picking marbles with toes. BT includes tendem walk, side leg raises, sit to stand, side walk, back leg raise
Balance training exercises comprising of side walk, tandem walk, standing on one leg, walking with alternating arm raise up to 90 degrees
|
|
Active Comparator: control group
Balance training 3 days a week for 8 weeks.
|
Balance training exercises comprising of side walk, tandem walk, standing on one leg, walking with alternating arm raise up to 90 degrees
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mini BESTest
Time Frame: Baseline
|
Mini BESTest is a 27-item physical performance test that distributes the items among the six sub-systems of static and dynamic balance, including stability limits/verticality, biomechanical constraints, anticipatory postural adjustments, postural responses, sensory orientation and stability in gait.
|
Baseline
|
|
Mini BESTest
Time Frame: At 4 weeks
|
Mini BESTest is a 27-item physical performance test that distributes the items among the six sub-systems of static and dynamic balance, including stability limits/verticality, biomechanical constraints, anticipatory postural adjustments, postural responses, sensory orientation and stability in gait.
|
At 4 weeks
|
|
Mini BESTest
Time Frame: At 8 weeks
|
Mini BESTest is a 27-item physical performance test that distributes the items among the six sub-systems of static and dynamic balance, including stability limits/verticality, biomechanical constraints, anticipatory postural adjustments, postural responses, sensory orientation and stability in gait.
|
At 8 weeks
|
|
Sharpened Romberg (SR)
Time Frame: Baseline
|
The Sharpened Romberg (SR) has been proposed as a quick screening tool for balance.
SR requires the client to stand in tandem, with the heel of one foot touching the toe of the other foot, for 30 or 60 seconds.
|
Baseline
|
|
Sharpened Romberg (SR)
Time Frame: At 4 weeks
|
The Sharpened Romberg (SR) has been proposed as a quick screening tool for balance.
SR requires the client to stand in tandem, with the heel of one foot touching the toe of the other foot, for 30 or 60 seconds.
|
At 4 weeks
|
|
Sharpened Romberg (SR)
Time Frame: At 8 weeks
|
The Sharpened Romberg (SR) has been proposed as a quick screening tool for balance.
SR requires the client to stand in tandem, with the heel of one foot touching the toe of the other foot, for 30 or 60 seconds.
|
At 8 weeks
|
|
Douleur Neuropathique 4 (DN4) Questionnaire
Time Frame: Baseline
|
The Douleur Neuropathique 4 (DN4) Questionnaire is a screening tool for neuropathic pain that includes physical exams and 10 interview questions (DN4-interview).
As referred in its original version scores lower than 4 were defined negative and 4 or more as positive.
|
Baseline
|
|
Douleur Neuropathique en 4 (DN4) Questionnaire
Time Frame: At 4 weeks
|
The Douleur Neuropathique 4 (DN4) Questionnaire is a screening tool for neuropathic pain that includes physical exams and 10 interview questions (DN4-interview).
As referred in its original version scores lower than 4 were defined negative and 4 or more as positive.
|
At 4 weeks
|
|
Douleur Neuropathique en 4 (DN4) Questionnaire
Time Frame: At 8 weeks
|
The Douleur Neuropathique 4 (DN4) Questionnaire is a screening tool for neuropathic pain that includes physical exams and 10 interview questions (DN4-interview).
As referred in its original version scores lower than 4 were defined negative and 4 or more as positive.
|
At 8 weeks
|
|
Unilateral stance test
Time Frame: Baseline
|
Unilateral stance test is used for postural stability.
The participant must stand unsupported on one leg.
Participants are more likely to fall hurt if they can't maintain the one-leg position for at least five seconds.
|
Baseline
|
|
Unilateral stance test
Time Frame: At 4 weeks
|
Unilateral stance test is used for postural stability.
The participant must stand unsupported on one leg.
Participants are more likely to fall hurt if they can't maintain the one-leg position for at least five seconds.
|
At 4 weeks
|
|
Unilateral stance test
Time Frame: At 8 weeks
|
Unilateral stance test is used for postural stability.
The participant must stand unsupported on one leg.
Participants are more likely to fall hurt if they can't maintain the one-leg position for at least five seconds.
|
At 8 weeks
|
|
The Falls Efficacy Scale International (FES-I)
Time Frame: Baseline
|
The Falls Efficacy Scale International (FES-I) measures people's fear about falling.
FES-I scores ranging from minimum 7 (no concern about falling) to maximum 28 could be used as a rapid screening tool to evaluate a person's self-reported fear of falling.
|
Baseline
|
|
The Falls Efficacy Scale International (FES-I)
Time Frame: At 4 weeks
|
The Falls Efficacy Scale International (FES-I) measures people's fear about falling.
FES-I scores ranging from minimum 7 (no concern about falling) to maximum 28 could be used as a rapid screening tool to evaluate a person's self-reported fear of falling.
|
At 4 weeks
|
|
The Falls Efficacy Scale International (FES-I)
Time Frame: At 8 weeks
|
The Falls Efficacy Scale International (FES-I) measures people's fear about falling.
FES-I scores ranging from minimum 7 (no concern about falling) to maximum 28 could be used as a rapid screening tool to evaluate a person's self-reported fear of falling.
|
At 8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Kiran Khushnood, MSNMPT, Riphah International University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 5, 2023
Primary Completion (Actual)
August 30, 2023
Study Completion (Actual)
September 30, 2023
Study Registration Dates
First Submitted
April 12, 2023
First Submitted That Met QC Criteria
May 4, 2023
First Posted (Actual)
May 8, 2023
Study Record Updates
Last Update Posted (Actual)
October 12, 2023
Last Update Submitted That Met QC Criteria
October 11, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RIPHAH/FR&AHS/Letter-014124
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetic Peripheral Neuropathy
-
Chongqing Medical UniversityFirst Affiliated Hospital of Chongqing Medical UniversityRecruitingDiabetic Peripheral NeuropathyChina
-
Riphah International UniversityNot yet recruitingDiabetic Peripheral NeuropathyPakistan
-
Montiha AzeemRecruitingDiabetic Peripheral NeuropathyPakistan
-
Beni-Suef UniversityNot yet recruitingDiabetic Peripheral NeuropathyEgypt
-
Ain Shams UniversityRecruitingDiabetic Peripheral Neuropathy | Diabetic Neuropathy | Diabetic Peripheral Neuropathy in Type 2 Diabetic PatientsEgypt
-
University of FaisalabadActive, not recruitingDiabetic Peripheral NeuropathyPakistan
-
Lisa GriffinRecruitingHealthy Aging | Diabetic Peripheral Neuropathy | Diabetic Peripheral Neuropathy Type 2 | Diabetic Peripheral Neuropathy Type 2 - UncontrolledUnited States
-
Min LongRecruiting
-
Riphah International UniversityRecruitingDiabetic Peripheral Neuropathy (DPN)Pakistan
-
Pamlab, L.L.C.HealthCore, Inc.CompletedDiabetic Peripheral Neuropathy (DPN)United States
Clinical Trials on Ankle proprioceptive training (APT)
-
University of ValenciaCompletedAging ProblemsSpain
-
Ankara UniversityCompletedExercise | Geriatric | Foot Ankle Injuries | Fall in Nursing HomeTurkey (Türkiye)
-
KU LeuvenUniversitaire Ziekenhuizen KU LeuvenCompleted
-
Karolinska InstitutetRegion Stockholm; Promobilia Foundation; Stroke Foundation; KID-medelCompleted
-
University of Paris 5 - Rene DescartesAssistance Publique - Hôpitaux de ParisCompletedAlzheimer Disease | Mild Cognitive ImpairmentFrance
-
Shirley Ryan AbilityLabCompleted
-
Riphah International UniversityRecruitingSports Physical TherapyPakistan
-
Superior UniversityActive, not recruiting
-
Hasselt UniversityKU LeuvenRecruitingLow Back Pain | Back Pain Lower Back ChronicBelgium
-
Investigación en Hemofilia y FisioterapiaCompletedProprioceptive DisordersSpain